PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
April 5, 2026Cancer Research

Abstract 4601: Rational design of potent androgen receptor degraders via AI-assisted molecular modeling and validation of anti-tumor efficacy in prostate cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

CCChih-Chang ChouYLYou-Sheng LinCCCheng-Li Chou

Discussion

Loading...

Member takes

Overview

A rational design approach developed effective AR degraders in prostate cancer, indicating a new treatment strategy.

Key Points

  • The aim is to develop novel androgen receptor degraders to improve treatment efficacy for prostate cancer.
  • Employed AIMCADD platform for molecular modeling of AR-LBD and CRBN.
  • Used molecular dynamics simulations to assess binding stability and affinity.
  • Conducted molecular docking and dynamic simulations for candidate evaluation.
  • Validated candidates in various prostate cancer cell lines and xenograft models.
  • Lead degraders effectively induced AR degradation in prostate cancer cells.
  • Suppressed proliferation with minimal toxicity in normal cells.
  • Demonstrated strong anti-tumor efficacy in xenograft models, reducing tumor size and PSA levels.
  • Showed activity against common AR mutants found in CRPC.

Cite This Study

Chou et al. (2026) studied this question.

synapsesocial.com/papers/69d1fdd4a79560c99a0a4137https://doi.org/10.1158/1538-7445.am2026-4601
View Full Paper
Ask AI
Bookmark
Share